Insider Trading July 2, 2026 09:10 PM

Procore Technologies Director Kevin J. O’Connor Executes $488,902 in Stock Sales via Rule 10b5-1 Plan

Insider transaction data reveals structured divestment by a Procore director, coinciding with mixed quarterly earnings and divergent analyst outlooks for the construction tech provider.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
PCOR

Procore Technologies, Inc. (NASDAQ: PCOR) director Kevin J. O’Connor has executed a series of stock sales totaling $488,902 through a pre-established Rule 10b5-1 trading plan. The transactions, which occurred on July 1 and July 2, 2026, were conducted indirectly via the Kevin J. O’Connor Revocable Trust. This insider activity unfolds against a backdrop of mixed financial results for the construction software provider, which recently reported first-quarter 2026 earnings that missed consensus estimates on profit per share despite beating revenue projections. The stock has experienced significant volatility, declining 37% over the past six months while posting a modest 4.9% gain in the preceding week.

Procore Technologies Director Kevin J. O’Connor Executes $488,902 in Stock Sales via Rule 10b5-1 Plan
PCOR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Procore Technologies director Kevin J. O’Connor sold 11,538 shares worth $488,902 via a Rule 10b5-1 plan established in March 2026.
  • The company reported first-quarter 2026 earnings with revenue of $359.28 million, beating estimates, but EPS of $0.34 missed the $0.36 forecast.
  • Analyst opinions on Procore remain divided, with D.A. Davidson maintaining a Neutral rating and Stifel reaffirming a Buy rating.

Kevin J. O’Connor, serving as a director at Procore Technologies, Inc. (NASDAQ: PCOR), has completed the disposal of 11,538 shares of the company's common stock. The divestment was executed across three distinct transactions on July 1 and July 2, 2026, resulting in a total realized value of $488,902. These transactions were not conducted in the open market but were instead facilitated indirectly through the Kevin J. O’Connor Revocable Trust U/A DTD 06-13-19. The sales were structured pursuant to a Rule 10b5-1 trading plan, a mechanism designed to allow insiders to trade stock during restricted periods, which O’Connor originally established on March 13, 2026.


The initial transaction occurred on July 1, involving the sale of 5,769 shares. These shares were disposed of at a weighted average price of $41.93 per share, with individual execution prices fluctuating between $41.82 and $42.115. The subsequent activity took place on July 2, where two separate sales were executed. The first of these daily transactions involved 1,697 shares sold at a weighted average price of $42.40 per share, with prices ranging from $41.74 to $42.735. The second sale on July 2 consisted of 4,072 shares, which were sold at a weighted average price of $42.99 per share, with individual prices spanning from $42.76 to $43.19.


Following the completion of these transactions, O’Connor’s indirect holdings in Procore Technologies common stock stand at 962,132 shares. In addition to these indirect holdings, the director maintains a direct portfolio position of 21,344 shares of common stock. The timing of these sales coincides with a period of mixed market performance for Procore. Over the past week, the stock posted a 4.9% gain, yet it has declined 37% over the preceding six months. According to InvestingPro analysis, the shares currently trade below their estimated Fair Value, suggesting the stock may be undervalued at current levels. Investors seeking deeper insights can access 11 additional InvestingPro Tips for PCOR.


Procore Technologies recently reported its first-quarter 2026 earnings, presenting a mixed financial picture. The company exceeded revenue expectations, reporting $359.28 million in revenue, which surpassed the forecasted $352.82 million. However, the company's earnings per share (EPS) fell short of consensus estimates, posting $0.34 compared to the anticipated $0.36. Following these results, D.A. Davidson maintained a Neutral rating on Procore, with a price target of $55.00, citing concerns over the company’s margin outlook. Meanwhile, Stifel reiterated its Buy rating and set a $63.00 price target after a jobsite tour with Benchmark Builders, a contractor involved in a significant project for Foot Locker in New York City.


The recent developments highlight varying analyst perspectives on Procore’s financial performance and future prospects. The divergence in analyst opinions, combined with the insider stock sales, provides a snapshot of the complex dynamics surrounding the construction technology sector. The stock's recent price action, including a closed price of 43.97 with a +1.83 (+4.34%) change, and an after-hours price of 44.23 with a +0.26 (+0.60%) change, reflects ongoing market evaluation of the company's trajectory.

Risks

  • Procore's earnings per share missed consensus estimates, raising concerns about the company's margin outlook as cited by D.A. Davidson.
  • The stock has experienced significant volatility, declining 37% over the last six months, indicating potential market uncertainty for construction tech investors.
  • Divergent analyst price targets ($55.00 from D.A. Davidson vs. $63.00 from Stifel) highlight uncertainty regarding the company's near-term valuation and growth trajectory.

More from Insider Trading

Spyre Therapeutics CFO Executes Pre-Arranged Share Sales Amid Clinical Momentum Jul 2, 2026 Lightspeed Affiliates Divest $260K in Navan Shares Amid Post-IPO Restructuring Jul 2, 2026 Lightspeed Management Exits Navan Position; Company Pursues Strategic Acquisitions and AI Integrations Jul 2, 2026 Spyre Therapeutics CMO Sheldon Sloan Liquidates Holdings Following $730K Sale Jul 2, 2026 Spyre Therapeutics CEO Cameron Turtle Sells $1.32M in Shares Amid Pipeline Progress Jul 2, 2026